Get the Stockscreener App
338.72
0.14%
0.46
Pre-market:
338.72
Penumbra Inc stock is traded at $338.72, with a volume of 778.06K.
It is up +0.14% in the last 24 hours and up +6.03% over the past month.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
See More
Previous Close:
$338.26
Open:
$338.05
24h Volume:
778.06K
Relative Volume:
0.86
Market Cap:
$13.29B
Revenue:
$1.24B
Net Income/Loss:
$42.23M
P/E Ratio:
319.55
EPS:
1.06
Net Cash Flow:
$150.33M
1W Performance:
-0.96%
1M Performance:
+6.03%
6M Performance:
+36.28%
1Y Performance:
+26.83%
1-Day Range:
$338.05
$340.34
1-Week Range:
$337.63
$344.07
52-Week Range:
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
338.72 | 13.27B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Nov-18-25 | Initiated | Wells Fargo | Underweight |
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
The Truth About Penumbra Inc: Why Wall Street Is Watching While TikTok Sleeps On It - AD HOC NEWS
Wesbanco Bank Inc. Purchases New Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra (PEN) Projected to Post Earnings on Tuesday - MarketBeat
Has Penumbra (PEN) Risen Too Far After Strong One Year Share Price Gain? - Yahoo Finance
Penumbra Sale To Boston Scientific Recasts Growth Story For Investors - Sahm
Penumbra, Inc. $PEN Stock Holdings Lowered by Principal Financial Group Inc. - MarketBeat
Penumbra (PEN) Reported Revenue Growth of 16.9% in Q4 - Insider Monkey
AGF Management Ltd. Makes New $3.14 Million Investment in Penumbra, Inc. $PEN - MarketBeat
Hantz Financial Services Inc. Lowers Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (PEN): A Bull Case Theory - Finviz
Boston Scientific earnings on deck after Q3 miss, Penumbra deal By Investing.com - Investing.com Canada
AI Stocks: Is Penumbra Inc on track to beat earningsJuly 2025 Momentum & Risk Managed Investment Signals - baoquankhu1.vn
Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm’s Investigations - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Thrivent Financial for Lutherans Purchases 44,185 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. $PEN Shares Acquired by New York State Common Retirement Fund - MarketBeat
Penumbra Acquisition Finalized in Multi-Billion Dollar Deal with Boston Scientific - AD HOC NEWS
Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals - Yahoo Finance
Penumbra, Inc. (NYSE:PEN) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Y Intercept Hong Kong Ltd Cuts Position in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific (BSX) garnering bullish views amid Penumbra acquisition - MSN
Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings - TechStock²
Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition - Yahoo Finance
Hussman Strategic Advisors Inc. Makes New Investment in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific to acquire Alameda-based Penumbra for $14.5 billion - MSN
Halper Sadeh LLC Investigates Penumbra and RAPT Transactions - intellectia.ai
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants - FinancialContent
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA - Sahm
Halper Sadeh Investigates Potential Violations by Penumbra, Amicus, DigitalBridge, and Flushing Financial - intellectia.ai
Strs Ohio Cuts Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific Buyout Caps Penumbra Upside And Shifts Investor Focus - Sahm
EFG Asset Management North America Corp. Acquires 3,631 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra launches next-gen Lightning Flash 3.0 thrombectomy system - MassDevice
Fed Meeting: Is Penumbra Inc likely to announce a buybackJuly 2025 Rallies & Daily Profit Focused Stock Screening - baoquankhu1.vn
Boston Scientific Penumbra Deal Recasts Growth Prospects In Thrombectomy And Neurovascular - Sahm
Baillie Gifford & Co. Sells 13,581 Shares of Penumbra, Inc. $PEN - MarketBeat
Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. - Barron's
Price Over Earnings Overview: Penumbra - Benzinga
Oppenheimer Questions Valuation of Boston Scientific’s $14.5 Billion Penumbra Deal - Yahoo Finance
Boston Scientific announces agreement to acquire Penumbra, Inc. - Quantisnow
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—PEN, DBRG, FFIC, and FOLD - GlobeNewswire
Halper Sadeh Investigates Potential Securities Violations by Penumbra, Exact Sciences, DigitalBridge, and Flushing Financial - Intellectia AI
Boston Sci secures CE mark for Embold system - BioWorld MedTech
Penumbra (NYSE:PEN) Sets New 52-Week HighWhat's Next? - MarketBeat
Penumbra Inc stock hits all-time high at 352.3 USD By Investing.com - Investing.com Nigeria
Boston Scientific (BSX) to acquire Penumbra in $14.5B neurovascular push - Stock Titan
Halper Sadeh Investigates Penumbra and Others for Potential Violations - Intellectia AI
Penumbra (PEN) Sees Downgrade with Revised Price Target from Can - GuruFocus
Risk Report: Is ALTGs ROE strong enoughJuly 2025 Big Picture & Weekly Setup with High ROI Potential - baoquankhu1.vn
Boston Scientific to acquire Penumbra (NYSE: PEN) in $14.5B deal - Stock Titan
3 takeaways from Boston Scientific’s $14.5B Penumbra deal - MedTech Dive
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):